Hipro Biotechnology Co.,Ltd
Hipro Biotechnology Co.,Ltd
Contact Us
SARS-CoV-2 Antibody

Cardiovascular Test

AHA released "Cerebellum and Stroke Statistics (2017 version)" and the latest "China Cardiovascular Disease Report" showed that: China's cardiovascular disease accounts for more than 40% of the population's disease, and there are 2 deaths for every 5 diseases. He died of cardiovascular disease, including coronary heart disease, stroke, heart failure, and other major diseases with acute onset, dangerous conditions, and high mortality. The incidence or mortality rate is increasing every year. At present, it is estimated that there are 290 million cardiovascular patients in the country. Among them, there are at least 13 million stroke patients and 11 million patients with coronary heart disease. Cardiovascular diseases generally have acute morbidity and dangerous conditions. The effect of treatment is often inversely proportional to time. Therefore, the indicators for cardiovascular disease must be tested and the cardiac diagnostic tests must be fast, easy, and have high sensitivity and specificity. As a professional medical reagents manufacturer in China, Hipro can provide you with cardiovascular disease tests at consistently high quality.

Types of Cardiovascular Test

Products
Contact Us
Get in Touch
WHAT'S NEW AT HIPRO